Media
Relations
|
|
|
Esra
Erkal-Paler
|
UK/Global
|
+44 203
749 5638
|
Karen
Birmingham
|
UK/Global
|
+44 203
749 5634
|
Rob
Skelding
|
UK/Global
|
+44 203
749 5821
|
Matt
Kent
|
UK/Global
|
+44 203
749 5906
|
Jacob
Lund
|
Sweden
|
+46
8 553 260 20
|
Michele
Meixell
|
US
|
+1 302
885 2677
|
|
|
|
Investor
Relations
|
|
|
Thomas
Kudsk Larsen
|
|
+44 203
749 5712
|
Craig
Marks
|
Finance,
Fixed Income, M&A
|
+44
7881 615 764
|
Henry
Wheeler
|
Oncology
|
+44 203
749 5797
|
Mitchell
Chan
|
Oncology
|
+1 240
477 3771
|
Christer
Gruvris
|
Diabetes;
Autoimmunity, Neuroscience & Infection
|
+44 203
749 5711
|
Nick
Stone
|
Respiratory;
Brilinta
|
+44 203
749 5716
|
US toll
free
|
|
+1 866
381 7277
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
a)
|
Name
|
Sean
Bohen
|
|
2
|
Reason for the notification
|
||
a)
|
Position/status
|
Person
discharging managerial responsibilities
|
|
b)
|
Initial notification /Amendment
|
Initial
notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
AstraZeneca
PLC
|
|
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
|
|
4i
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
AstraZeneca
PLC American Depositary Shares
CUSIP:
046353108
|
|
b)
|
Nature of the transaction
|
Acquisition
of ADSs pursuant to vesting under the AstraZeneca Restricted Share
Plan, for nil consideration.
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
|
0
|
12,385
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
|
|
e)
|
Date of the transaction
|
25
September 2017
|
|
f)
|
Place of the transaction
|
Outside
a trading venue
|
|
AstraZeneca
PLC
|
|
By: /s/
Adrian Kemp
|
|
Name:
Adrian Kemp
|
|
Title:
Company Secretary
|